MK-677 (Ibutamoren): What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and MK-677 is not approved for human or veterinary use.

What is MK-677?

MK-677 (Ibutamoren) is an orally active, non-peptide compound studied in the research literature as a ghrelin-receptor (GHSR) agonist and growth-hormone secretagogue. Unlike peptide secretagogues, it is a small molecule, which is why it is often examined in oral-format research.

Where MK-677 sits in the research literature

The compound has been studied in a range of preclinical and clinical research settings focused on the growth-hormone axis. It is not an approved medicine, and any research findings should be interpreted within their study context.

Reported areas of preclinical interest

• Ghrelin receptor agonism: studied as a GHSR agonist affecting the growth-hormone axis in laboratory models.
• GH and IGF-1 signalling: examined for effects on growth-hormone-axis markers in research.

Why the “research use only” label matters

MK-677 is not approved as a medicinal product and is prohibited in competitive sport by WADA. It is supplied strictly for laboratory and scientific research and is not for human or veterinary consumption.

Handling and storage

Keep cool, dry and away from light, and follow the documentation supplied with each batch.

Frequently asked questions

What does MK-677 do in research?

It is studied as an orally active ghrelin-receptor agonist that acts on the growth-hormone axis in laboratory models.

Is MK-677 approved for human use?

No. It is a research compound only and is not intended for human or veterinary use, and it is banned in sport.

Key takeaways

MK-677 (Ibutamoren) is an orally active GH secretagogue studied in growth-hormone-axis research. It is a research material only and is prohibited in sport. Review the MK-677 research product.

References

References sourced via PubMed.

1. Murphy MG, Plunkett LM, Gertz BJ, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320-325. DOI · PubMed 9467534.
2. Lee J, Kwon A, Chae HW, et al. Effect of the orally active growth hormone secretagogue MK-677 on somatic growth in rats. Yonsei Med J. 2018;59(10):1174-1180. DOI · PubMed 30450851.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.